For persistent depression, FDA approves a novel treatment based on ketamine - Los Angeles Times

For persistent depression, FDA approves a novel treatment based on ketamine  Los Angeles TimesFor people with intractable depression, the FDA has approved a nasal spray called esketamine, which can take effect in hours, compared to weeks or months for ...